1,25-Dihydroxyvitamin D as Monotherapy for XLH: Back to the Future?

J Bone Miner Res. 2016 May;31(5):925-8. doi: 10.1002/jbmr.2858.

Authors

Diana Ovejero¹, Rachel I Gafni¹, Michael T Collins¹

Affiliation

¹ Section on Skeletal Disorders and Mineral Homeostasis, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.

PMID: 27093323
DOI: 10.1002/jbmr.2858

No abstract available

Publication types

Research Support, N.I.H., Intramural
Comment

MeSH terms

24,25-Dihydroxyvitamin D 3
Calcitriol
Familial Hypophosphatemic Rickets*
Humans
Hypophosphatemia, Familial*
Phosphates
Vitamin D / analogs & derivatives

Substances

Phosphates
Vitamin D
24,25-Dihydroxyvitamin D 3
1,25-dihydroxyvitamin D
Calcitriol